HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells

Journal of Cell Biology

Volumn 174, Issue 7, 2006, Pages 1059-1069

  Zeng, Lingfang ^a   Xiao, Qingzhong ^a   Margariti, Andriana ^a   Zhang, Zhongyi ^a   Zampetaki, Anna ^a   Patel, Seema ^a   Capogrossi, Maurizio C ^b   Hu, Yanhua ^a   Xu, Qingbo ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P21; PROTEIN P53; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DEACETYLATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ENZYME ACTIVATION; FEMORAL ARTERY; INTIMA; LAMINAR FLOW; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHEAR STRESS; SIGNAL TRANSDUCTION;

ACETYLATION; ANIMALS; APOLIPOPROTEINS E; BLOOD VESSELS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EMBRYO; ENDOTHELIAL CELLS; GENE DELETION; HISTONE DEACETYLASES; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; RNA, SMALL INTERFERING; STEM CELLS; STRESS, MECHANICAL; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33749027242     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200605113     Document Type: Article

References (47)

1. Akimoto, S., M. Mitsumata, T. Sasaguri, and Y. Yoshida. 2000. Laminar shear stress inhibits vascular endothelial cell proliferation by inducing cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1). Circ. Res. 86:185-190.
2. Bruhl, T., C. Heeschen, A. Aicher, A.S. Jadidi, J. Haendeler, J. Hoffmann, M.D. Schneider, A.M. Zeiher, S. Dimmeler, and L. Rossig. 2004. p21Cip1 levels differentially regulate turnover of mature endothelial cells, endothelial progenitor cells, and in vivo neovascularization. Circ. Res. 94:686-692.
3. Byrne, A.M., D.J. Bouchier-Hayes, and J.H. Harmey. 2005. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J. Cell. Mol. Med. 9:777-794.
4. Claesson-Welsh, L. 2003. Signal transduction by vascular endothelial growth factor receptors. Biochem. Soc. Trans. 31:20-24.
5. Coultas, L., K. Chawengsaksophak, and J. Rossant. 2005. Endothelial cells and VEGF in vascular development. Nature. 438:937-945.
6. Cross, M.J., J. Dixelius, T. Matsumoto, and L. Claesson-Welsh. 2003. VEGF-receptor signal transduction. Trends Biochem. Sci. 28:488-494.
7. Di Stefano, V., S. Soddu, A. Sacchi, and G. D'Orazi. 2005. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage. Oncogene. 24:5431-5442.
8. Ferrara, N., H.P. Gerber, and J. LeCouter. 2003. The biology of VEGF and its receptors. Nat. Med. 9:669-676.
9. Fujio, Y., and K. Walsh. 1999. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J. Biol. Chem. 274:16349-16354.
10. Gray, S.G., and T.J. Ekstrom. 2001. The human histone deacetylase family. Exp. Cell Res. 262:75-83.
11. Harris, A.L. 2002. Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer. 2:38-47.
12. Hu, Y., F. Davison, Z. Zhang, and Q. Xu. 2003. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation. 108:3122-3127.
13. Hu, Y., Z. Zhang, E. Torsney, A.R. Afzal, F. Davison, B. Metzler, and Q. Xu. 2004. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J. Clin. Invest. 113:1258-1265.
14. Illi, B., A. Scopece, S. Nanni, A. Farsetti, L. Morgante, P. Biglioli, M.C. Capogrossi, and C. Gaetano. 2005. Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. Circ. Res. 96:501-508.
15. Ingber, D.E. 2002. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ. Res. 91:877-887.
16. Jin, Z.G., H. Ueba, T. Tanimoto, A.O. Lungu, M.D. Frame, and B.C. Berk. 2003. Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Circ. Res. 93:354-363.
17. Kaufman, D.S., R.L. Lewis, E.T. Hanson, R. Auerbach, J. Plendl, and J.A. Thomson. 2004. Functional endothelial cells derived from rhesus monkey embryonic stem cells. Blood. 103:1325-1332.
18. Kleinman, H.K., D. Philp, and M.P. Hoffman. 2003. Role of the extracellular matrix in morphogenesis. Curr. Opin. Biotechnol. 14:526-532.
19. Lai, L., B.L. Bohnsack, K. Niederreither, and K.K. Hirschi. 2003. Retinoic acid regulates endothelial cell proliferation during vasculogenesis. Development. 130:6465-6474.
20. Lin, K., P.P. Hsu, B.P. Chen, S. Yuan, S. Usami, J.Y. Shyy, Y.S. Li, and S. Chien. 2000. Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc. Natl. Acad. Sci. USA. 97:9385-9389.
21. Liu, L.T., H.C. Chang, L.C. Chiang, and W.C. Hung. 2003. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Cancer Res. 63:3069-3072.
22. Mattiussi, S., P. Turrini, L. Testolin, F. Martelli, G. Zaccagnini, A. Mangoni, L.M. Barlucchi, A. Antonini, B. Illi, C. Cirielli, et al. 2004. p21(Waf1/Cip1/Sdi1) mediates shear stress-dependent antiapoptotic function. Cardiovasc. Res. 61:693-704.
23. Mayr, M., C. Li, Y. Zou, U. Huemer, Y. Hu, and Q. Xu. 2000. Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J. 14:261-270.
24. Pittenger, M.F., and B.J. Martin. 2004. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95:9-20.
25. Ross, R. 1999. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:115-126.
26. Rossig, L., C. Urbich, T. Bruhl, E. Dernbach, C. Heeschen, E. Chavakis, K. Sasaki, D. Aicher, F. Diehl, F. Seeger, et al. 2005. Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J. Exp. Med. 201:1825-1835.
27. Sata, M. 2003. Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc. Med. 13:249-253.
28. Sawa, H., H. Murakami, Y. Ohshima, M. Murakami, I. Yamazaki, Y. Tamura, T. Mima, A. Satone, W. Ide, I. Hashimoto, and H. Kamada. 2002. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells. Brain Tumor Pathol. 19:77-81.
29. Schaper, W., and D. Scholz. 2003. Factors regulating arteriogenesis. Arterioscler. Thromb. Vasc. Biol. 23:1143-1151.
30. Schatteman, G.C., and O. Awad. 2004. Hemangioblasts, angioblasts, and adult endothelial cell progenitors. Anat Rec A Discov Mol Cell Evol Biol. 276:13-21.
31. Shen, Q., S.K. Goderie, L. Jin, N. Karanth, Y. Sun, N. Abramova, P. Vincent, K. Pumiglia, and S. Temple. 2004. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science. 304:1338-1340.
32. Takahashi, T., S. Yamaguchi, K. Chida, and M. Shibuya. 2001. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J. 20:2768-2778.
33. Vittet, D., M.H. Prandini, R. Berthier, A. Schweitzer, H. Martin-Sisteron, G. Uzan, and E. Dejana. 1996. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood. 88:3424-3431.
34. Walter, D.H., K. Rittig, F.H. Bahlmann, R. Kirchmair, M. Silver, T. Murayama, H. Nishimura, D.W. Losordo, T. Asahara, and J.M. Isner. 2002. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 105:3017-3024.
35. Waltregny, D., W. Glenisson, S.L. Tran, B.J. North, E. Verdin, A. Colige, and V. Castronovo. 2005. Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility. FASEB J. 19:966-968.
36. Wang, H., G.M. Riha, S. Yan, M. Li, H. Chai, H. Yang, Q. Yao, and C. Chen. 2005. Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line. Arterioscler. Thromb. Vasc. Biol. 25:1817-1823.
37. Werner, N., J. Priller, U. Laufs, M. Endres, M. Bohm, U. Dirnagl, and G. Nickenig. 2002. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibition. Arterioscler. Thromb. Vasc. Biol. 22:1567-1572.
38. Werner, N., S. Junk, U. Laufs, A. Link, K. Walenta, M. Bohm, and G. Nickenig. 2003. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ. Res. 93:e17-e24.
39. Wurmser, A.E., K. Nakashima, R.G. Summers, N. Toni, K.A. D'Amour, D.C. Lie, and F.H. Gage. 2004. Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature. 430:350-356.
40. Xu, Q. 2006. The impact of progenitor cells in atherosclerosis. Nat Clin Pract Cardiovasc Med. 3:94-101.
41. Xu, Q., Z. Zhang, F. Davison, and Y. Hu. 2003. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ. Res. 93:e76-e86.
42. Yamamoto, K., T. Takahashi, T. Asahara, N. Ohura, T. Sokabe, A. Kamiya, and J. Ando. 2003. Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. J. Appl. Physiol. 95:2081-2088.
43. Yamamoto, K., T. Sokabe, T. Watabe, K. Miyazono, J.K. Yamashita, S. Obi, N. Ohura, A. Matsushita, A. Kamiya, and J. Ando. 2005. Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro. Am. J. Physiol. Heart Circ. Physiol. 288:H1915-H1924.
44. Yamashita, J., H. Itoh, M. Hirashima, M. Ogawa, S. Nishikawa, T. Yurugi, M. Naito, and K. Nakao. 2000. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 408:92-96.
45. Zachary, I. 2003. VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochem. Soc. Trans. 31:1171-1177.
46. Zeng, L., Y. Zhang, S. Chien, X. Liu, and J.Y. Shyy. 2003. The role of p53 deacetylation in p21Waf1 regulation by laminar flow. J. Biol. Chem. 278:24594-24599.
47. Zhao, Y., S. Lu, L. Wu, G. Chai, H. Wang, Y. Chen, J. Sun, Y. Yu, W. Zhou, Q. Zheng, et al. 2006. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Mol. Cell. Biol. 26:2782-2790.